Class II

Drug Recall: Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64

Genentech, Inc. · May 20, 2024

Reason for Recall

Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.

Distribution

Nationwide within the United States

States Affected

NATIONWIDE

Quantity Affected

Lot:3618858 = 105,759; Lot:3618873 =90,359

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0509-2024

Status: terminated

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.